To investigate the effect of blocking the expression of hALR with small interfering RNA (siRNA) targeting ALR on the expression of TGF-α and EGFR of HCC cell line HepG2. Methods: The expressing siRNA plasmid pSIALR-A targeting hALR and the unrelated control plasmid pSIALR-B were transfected into HepG2 cells with lipofectamine 2000 methods, respectively. The expression of green fluorescent protein was observed under a fluorescent microscope to calculate transfection efficiency. The protein level of hALR in the transfected cells was measured by immunocytochemistry to determine the inhibitory effect. According to different plasmid transfection, HepG2 cells were divided into three groups: transfection group (transfected pSIALR-A), the control group (transfected pSIALR-B), blank control group (non-transfected with the recombinant plasmid). The expression of TGF-α in the cell culture supernatant was detected by radioimmunoassay, the expression of EGFR was detected by Western blot. Results: In transfection group, blank group and the unrelated control group, expression of TGF-α is (5.27±0.86) pg/ml, (7.92±2.65) pg/ml and (6.50±1.28) pg/ml, respectively,the difference of transfection group and blank group, transfection group and the unrelated control group was statistically significant (P<0.05); the relative expression of EGFR is 0.946±0.136, 1.115±0.606 and 1.131±0.509, respectively,the difference of transfection group and blank group, transfection group and the unrelated control group was statistically significant (P<0.05). Conclusion: In the complex cytokine network which promotes the growth of hepatomas, augmenter of liver regeneration played an important role in the occurrence and development of hepatic carcinoma not only by stimulating hepatomas proliferation directely but also by up-regulating the expression level of TGF-α and EGFR.
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Materials and Methods: Wistar albino male rats (body weight (bw), 160-200 g) were divided into three groups: group I received pyrazinamide per os at a dose of 1000 mg/kg bw/day, group II -a dose of 2000 mg/kg bw/day, in both group it was given for 60 days; the control group was composed of intact animals. The contents of free amino acids in the liver, lung and spleen were determined using an amino acid analyzer ÀÀÀ-881 (Czech Republic).
Results and Discussion:
The study of the effects of pyrazinamide on the liver, lung and spleen contents of free amino acids in the rats showed the largest number of changes in the liver at a dose 1000 mg/kg bw/day and in the lung and spleen -at a dose 2000mg/kg bw/day. At a dose 2000mg/kg in the lung, the content of free amino acids at the level of 18 amino acids and total sum of amino acids significantly differed from controls. In the spleen, this difference was observed at the level of 14 amino acids and total sum of amino acids.
Conclusions:
The study of the influence of pyrazinamide on liver, lung and spleen contents of free amino acids allows to fully estimate the dose-dependent effects of this substance on metabolic processes in these organs. 
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